Treatment with controlled-release lovastatin decreases serum concentrations of human ²-amyloid (A²) peptide.

Autor: Friedhoff, Lawrence T., Cullen, Edward I., Geoghagen, Neil S. M., Buxbaum, Joseph D.
Zdroj: International Journal of Neuropsychopharmacology; Apr2001, Vol. 4 Issue 2, p127-130, 4p
Databáze: Complementary Index